"Biomarkers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc.
Descriptor ID |
D015415
|
MeSH Number(s) |
D23.101
|
Concept/Terms |
Biomarkers- Biomarkers
- Markers, Biological
- Biologic Markers
- Markers, Biologic
- Biologic Marker
- Marker, Biologic
- Marker, Biological
- Biological Marker
- Biological Markers
Serum Markers- Serum Markers
- Markers, Serum
- Marker, Serum
- Serum Marker
Surrogate Endpoints- Surrogate Endpoints
- Endpoints, Surrogate
- Surrogate End Points
- End Points, Surrogate
- Surrogate End Point
- End Point, Surrogate
- Surrogate Endpoint
- Endpoint, Surrogate
Viral Markers- Viral Markers
- Markers, Viral
- Viral Marker
- Marker, Viral
Biochemical Marker- Biochemical Marker
- Biochemical Markers
- Markers, Biochemical
- Marker, Biochemical
Markers, Immunologic- Markers, Immunologic
- Immune Markers
- Markers, Immune
- Marker, Immunologic
- Immunologic Markers
- Immune Marker
- Marker, Immune
- Immunologic Marker
Surrogate Markers- Surrogate Markers
- Markers, Surrogate
- Marker, Surrogate
- Surrogate Marker
|
Below are MeSH descriptors whose meaning is more general than "Biomarkers".
Below are MeSH descriptors whose meaning is more specific than "Biomarkers".
This graph shows the total number of publications written about "Biomarkers" by people in this website by year, and whether "Biomarkers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 5 | 6 |
1996 | 2 | 8 | 10 |
1997 | 1 | 10 | 11 |
1998 | 1 | 5 | 6 |
1999 | 1 | 13 | 14 |
2000 | 1 | 16 | 17 |
2001 | 1 | 14 | 15 |
2002 | 2 | 23 | 25 |
2003 | 2 | 27 | 29 |
2004 | 3 | 21 | 24 |
2005 | 1 | 42 | 43 |
2006 | 3 | 47 | 50 |
2007 | 4 | 50 | 54 |
2008 | 13 | 43 | 56 |
2009 | 5 | 47 | 52 |
2010 | 8 | 66 | 74 |
2011 | 16 | 91 | 107 |
2012 | 8 | 74 | 82 |
2013 | 20 | 98 | 118 |
2014 | 17 | 106 | 123 |
2015 | 13 | 109 | 122 |
2016 | 24 | 102 | 126 |
2017 | 15 | 111 | 126 |
2018 | 20 | 118 | 138 |
2019 | 11 | 121 | 132 |
2020 | 16 | 116 | 132 |
2021 | 13 | 114 | 127 |
2022 | 4 | 90 | 94 |
2023 | 4 | 78 | 82 |
2024 | 35 | 46 | 81 |
2025 | 3 | 6 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biomarkers" by people in Profiles.
-
Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019. J Infect Dis. 2025 Mar 17; 231(3):677-683.
-
Clinical Performance of an N-Terminal Pro-B-Type Natriuretic Peptide Assay in Acute Heart Failure Diagnosis. J Appl Lab Med. 2025 Mar 03; 10(2):325-338.
-
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial. J Am Heart Assoc. 2025 Mar 04; 14(5):e038656.
-
Divergence in cellular markers observed in single-cell transcriptomics datasets between cultured primary trabecular meshwork cells and tissues. Sci Data. 2025 Feb 14; 12(1):264.
-
Development and validation of predictive models of early immune effector cell-associated hematotoxicity. Blood Adv. 2025 Feb 11; 9(3):606-616.
-
Preeclampsia biomarkers (sFlt-1/PlGF) dynamics are not disrupted by SARS-CoV-2 infection during pregnancy in a hypertensive disorder SARS-CoV-2 vaccinated cohort. Pregnancy Hypertens. 2025 Mar; 39:101196.
-
Comprehensive assessment reveals numerous clinical and neurophysiological differences between MECP2-allelic disorders. Ann Clin Transl Neurol. 2025 Feb; 12(2):433-447.
-
Distinct plasma lipids predict axonal injury and multiple sclerosis activity. J Neurol Neurosurg Psychiatry. 2025 Jan 16; 96(2):150-157.
-
Mid-life anti-inflammatory metabolites are inversely associated with long-term cardiovascular disease events. EBioMedicine. 2025 Feb; 112:105551.
-
Brain-type natriuretic peptide is a useful biomarker of cardiovascular disease and predictor of cardiac-related mortality in chimpanzees (Pan troglodytes). Am J Vet Res. 2025 Mar 01; 86(3).